González TVM, Gómez TJC, Bazán BA, Ochoa DD, González GA, Portilla FVH

Idioma: Español
Referencias bibliográficas: 28
Paginas: 10-15
Archivo PDF: 65.16 Kb.

RESUMEN

Objetivo. Evaluar la sobrevida del injerto renal de donador cadavérico conforme a la compatibilidad de HLA, realizados en el Hospital Juárez de México. Material y métodos. Revisión de expedientes clínicos desde el inicio de la determinación de Antígeno Leucocitario Humano (HLA) en pacientes en lista de espera para donación cadavérica, se revisaron 22 expedientes. Resultados. Encontramos una función del injerto viable en pacientes sin compatibilidad HLA, a un mes, de 85%; a seis meses, de 71%; a 12 meses, de 57%; a 18 meses, de 28%; a 24 meses, de 14%. Comparado con la función del injerto viable en pacientes con compatibilidad HLA a un mes, de 86%; a seis meses, de 78%; a 12 meses, de 63%; a 18 meses, de 45%, a 24 meses de 44%. Conclusiones. Se observó en este estudio una mejor sobrevida del injerto con la presencia de compatibilidad HLA, comparándose contra los que no presentan compatibilidad HLA.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Opelz G, Wujciak T. Cadaveric kidneys should be allocated according to the HLA match. Transplant Proc 1995; 27(1): 93.

2. Gabriel M. Danovitch. Handbook of Kidney Transplantation. Fourth edition. 2005: 23-71.

3. McKenna RM, Lee KR, Gough JC, et al. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation 1998; 66(1):

4. Dyer, PA, Class, FHJ. A future for HLA matching in clinical transplantation. European Journal of Immunogenetics. Vol. 24(1) February 1997: 17-28.

5. Zantvoort FA, D´Amaro J, Persijn GG, Cohen B, Schreuder G, Van Rood J, Thorogood J. The impact of HLA-A matching on Long-term survival of renal allografts. Transplantation Volume 61(5) 15 march 1996: 841-4.

6. Opelz G. Impact of HLA compatibility on survival of Kidney transplants from unrelated live donors. Transplantation Volume 64(10), 27 November 1997: 1473-5.

7. Taylor, Craig J, Dyer P. Evaluation of HLA matching for CREG antigens in Europe. Transplantation 1999; 68: 1093-4.

8. Higgins RM, West N, Edmunds, et al. Effect of a strict HLA matching policy on distribution of cadaveric kidney transplant to Indo-Asian and white European recipients: regional study. British Medical Journal. Volume 315(7119), 22 November 1997: 1354-5.

9. Opelz G, Scherer S, et al. Analysis of HLA-DR split-specificity matching in cadaver kidney transplantation: A report of the collaborative transplant study. Transplantation. Volume 63(1) 15 January 1997: 57-9.

10. Van Rood, Jon J. Weighing optimal survival through HLA matching against the equitable distribution of Kidney allografts. The New England Journal of Medicine 2004; vol. 350(6): 535-6.

11. Sanfilippo F. HLA matching in renal transplantation. The New England Journal of Medicine. Volume 331(12): 803-4.

12. Caner S, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation vol. 73 No. 8 April 2002: 1269-73.

13. Schnitzler MA, Hollenbeak, et al. The economics implications of HLA matching in cadaveric renal transplantation. The New England Journal of Medicine.

14. Sumitran-Karuppan, Suchitra. The clinical importance of choosing the right assay for detection of HLA specific donor-reactive antibodies. Transplantation. Volume 68(4) August 1999: 502-9.

15. Takemoto S, Terasaki P, et al. Equitable allocation of HLA compatible Kidneys for local pools and for minorities. The New England Journal of Medicine. Vol 331(12) September 1994: 760-4.

16. Gaston RS, Ayres Ian, et al. Racial equity in renal transplantation : The disparate impact of HLA based allocation. JAMA. Vol 270(11) Sept. 1993: 1352-6.

17. Hickey DP. O’Malley, et al. Long term follow-up of a single center experience of sharing cadaver kidneys base on HLA-matching. Transplantation. Vol 67(9) May 1999: 554.

18. Starzl TE, Eliasziw M, et al. HLA and cross reactive antigen group matching for cadaver kidney allocation. Transplantation. Vol 64(7) October 1997: 983-91.

19. Held, Philip J, Kahan BD, et al. The impact of HLA mismatches on the survival of first cadaveric Kidney transplants. The New England Journal of Medicine. Vol 331(12) 22 Sept. 1994: 765-70.

20. Connolly JK, Dyer PA, et al. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation. Vol 61(5) 15 March 1996: 709-14.

21. Schnitzler MA, Woodward, et al. Cost of HLA mismatches in cadaveric renal transplant. Transplantation. Vol 67(7) 15 April 1999: 113.

22. McKenna RM, Lee KR. et al. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two year renal allograft function. Transplantation. Vol 66(1) July 1998: 38-43.

23. Kobayashi T, Yokoyama I, Uchida K, et al. The significance of HLA-DRB1 matching in clinical renal transplantation. Transplantation 1992; 54: 238.

24. Beckingham IJ, Dennis MJS, Bishop MC, Blamey RW, Smith SJ, Nicholson ML. Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation. Br J Surg 1994; 81: 574.

25. Edwards, Erick B, Bennett LE, Cekca J. Effect of HLA matching on the relative risk of mortality for kidney recipients: A comparison of the mortality risk after transplant to the mortality risk of remaining on the waiting list. Transplantation. Vol 64(9) 15 November 1997: 1274-7.

26. Barocci S, Vlente U, et al. HLA matching in pediatric recipients of first kidney graft: A single center analysis. Transplantation. Vol 61(1); January 1996: 151-4.

27. Pirch JD, Ploeg R, et al. Determinants of graft survival after renal transplantation. Transplantation. Vol 61(11) June 1996: 1581-86.

28. Opelz G for the Collaborative Transplant Study. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants. Transplant Proc 1987; 19: 641.